{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T11:28:39Z","timestamp":1769254119357,"version":"3.49.0"},"reference-count":138,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Systemic sclerosis (SSc) is a rare autoimmune connective tissue disorder characterized by massive fibrosis, vascular damage, and immune imbalance. Advances in rheumatology and immunology over the past two decades have led to a redefinition of systemic sclerosis, shifting from its initial perception as primarily a \u201chyperfibrotic\u201d state towards a recognition of systemic sclerosis as an immune-mediated disease. Consequently, the search for genetic markers has transitioned from focusing on fibrotic mechanisms to exploring immune regulatory pathways. Immunogenetics, an emerging field at the intersection of immunology, molecular biology, and genetics has provided valuable insights into inherited factors that influence immunity. Data from genetic studies conducted thus far indicate that alterations in genetic messages can significantly impact disease risk and progression. While certain genetic variations may confer protective effects, others may exacerbate disease susceptibility. This paper presents a comprehensive review of the most relevant genetic changes that influence both the risk and course of systemic sclerosis. Special emphasis is placed on factors regulating the immune response, recognizing their pivotal role in the pathogenesis of the disease.<\/jats:p>","DOI":"10.3390\/genes15050586","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T15:05:01Z","timestamp":1715007901000},"page":"586","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunogenetics of Systemic Sclerosis"],"prefix":"10.3390","volume":"15","author":[{"given":"Olga","family":"Gumkowska-Sroka","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Medical University of Silesia, Voivodeship Hospital No. 5, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kacper","family":"Kotyla","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Medical University of Silesia, Voivodeship Hospital No. 5, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8376-6527","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Kotyla","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Medical University of Silesia, Voivodeship Hospital No. 5, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: A prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Asano, Y. (2020). The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092687"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","article-title":"Incidence and prevalence of systemic sclerosis globally: A comprehensive systematic review and meta-analysis","volume":"60","author":"Bairkdar","year":"2021","journal-title":"Rheumatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-018-8718-8","article-title":"Antinuclear Antibodies in Systemic Sclerosis: An Update","volume":"58","author":"Stochmal","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_7","first-page":"202","article-title":"Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"ref_8","first-page":"S5","article-title":"A working classification of scleroderma spectrum disorders: A proposal and the results of testing on a sample of patients","volume":"22","author":"Maricq","year":"2004","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.2147\/JIR.S361667","article-title":"CREST Syndrome in Systemic Sclerosis Patients\u2014Is Dystrophic Calcinosis a Key Element to a Positive Diagnosis?","volume":"15","author":"Bobeica","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archinte.1979.03630480030012","article-title":"The\u2019CREST\u2019Syndrome: Comparison with Systemic Sclerosis (Scleroderma)","volume":"139","author":"Velayos","year":"1979","journal-title":"Arch. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1272\/jnms.84.56","article-title":"Circulating anti-nuclear antibodies in systemic sclerosis: Utility in diagnosis and disease subsetting","volume":"84","author":"Kuwana","year":"2017","journal-title":"J. Nippon. Med. Sch."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/BOR.0000000000000550","article-title":"An update on autoantibodies in scleroderma","volume":"30","author":"Mecoli","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"930970","DOI":"10.3389\/fimmu.2022.930970","article-title":"Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?","volume":"13","author":"Chepy","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3899\/jrheum.090207","article-title":"Systemic Sclerosis: Environmental Factors","volume":"36","author":"Mora","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.autrev.2018.11.001","article-title":"Systemic sclerosis and exposure to heavy metals","volume":"18","author":"Marie","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/1040841X.2019.1614904","article-title":"The role of viral infections in the development of autoimmune diseases","volume":"45","author":"Hussein","year":"2019","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0889-857X(05)70296-9","article-title":"Immunopathogenesis of systemic sclerosis","volume":"22","author":"White","year":"1996","journal-title":"Rheum. Dis. Clin."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Perricone, C., and Shoenfeld, Y. (2019). Mosaic of Autoimmunity, Academic Press.","DOI":"10.1016\/B978-0-12-814307-0.00037-2"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3389\/fimmu.2018.01702","article-title":"Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances","volume":"9","author":"Laurent","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/BOR.0000000000000907","article-title":"Type 1 interferon activation in systemic sclerosis: A biomarker, a target or the culprit","volume":"34","author":"Kakkar","year":"2022","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.rdc.2007.10.001","article-title":"Genetics and genomic studies in scleroderma (systemic sclerosis)","volume":"34","author":"Agarwal","year":"2008","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1445-5994.1999.tb01586.x","article-title":"Familial risk estimation in systemic sclerosis","volume":"29","author":"Englert","year":"1999","journal-title":"Aust. N. Z. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/1529-0131(200107)44:7<1654::AID-ART288>3.0.CO;2-O","article-title":"Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis","volume":"44","author":"Kuwana","year":"2001","journal-title":"Arthritis Rheum. Off. J. Am. Coll. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Wright","year":"2003","journal-title":"Arthritis Rheum. Off. J. Am. Coll. Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43586-021-00056-9","article-title":"Genome-wide association studies","volume":"1","author":"Uffelmann","year":"2021","journal-title":"Nat. Rev. Methods Primers"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/annrheumdis-2020-218558","article-title":"Genomic Risk Score impact on susceptibility to systemic sclerosis","volume":"80","author":"Kerick","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.gde.2015.06.005","article-title":"Genomic risk prediction of complex human disease and its clinical application","volume":"33","author":"Abraham","year":"2015","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.b.32705","article-title":"Predictive modeling of schizophrenia from genomic data: Comparison of polygenic risk score with kernel support vector machines approach","volume":"180","author":"Baker","year":"2019","journal-title":"Am. J. Med. Genetics. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM200009073431006","article-title":"The HLA system. First of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_31","unstructured":"Klein, J. (1986). Natural History of the Major Histocompatibility Complex, Wiley."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/138920207783591690","article-title":"The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action","volume":"8","author":"Gough","year":"2007","journal-title":"Curr. Genom."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41232-021-00167-6","article-title":"Updates on genetics in systemic sclerosis","volume":"41","author":"Ota","year":"2021","journal-title":"Inflamm. Regen."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/ard.2009.111906","article-title":"Major Histocompatibility Complex (MHC) class II alleles, haplotypes, and epitopes which confer susceptibility or protection in the fibrosing autoimmune disease systemic sclerosis: Analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls","volume":"69","author":"Arnett","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/art.24982","article-title":"HLA\u2013DPB1 and DPB2 are genetic loci for systemic sclerosis: A genome-wide association study in Koreans with replication in North Americans","volume":"60","author":"Zhou","year":"2009","journal-title":"Arthritis Rheum. Off. J. Am. Coll. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.gene.6363734","article-title":"Class II HLA associations with autoantibodies in scleroderma: A highly significant role for HLA-DP","volume":"2","author":"Gilchrist","year":"2001","journal-title":"Genes Immun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/sarh.2001.20268","article-title":"Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinants","volume":"30","author":"Reveille","year":"2001","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/tan.14793","article-title":"Association of HLA-DRB1*15:02:01, DQB1*05:01:24 and DPB1*13:01:01 in Thai patients with systemic sclerosis","volume":"100","author":"Louthrenoo","year":"2022","journal-title":"Hla"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Furukawa, H., Oka, S., Kawasaki, A., Shimada, K., Sugii, S., Matsushita, T., Hashimoto, A., Komiya, A., Fukui, N., and Kobayashi, K. (2016). Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154255"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"913196","DOI":"10.3389\/fgene.2022.913196","article-title":"Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes","volume":"13","author":"Hanson","year":"2022","journal-title":"Front. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"461739","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s42358-019-0107-3","article-title":"Evaluation of the association between KIR polymorphisms and systemic sclerosis: A meta-analysis","volume":"60","author":"Karimizadeh","year":"2020","journal-title":"Adv. Rheumatol."},{"key":"ref_44","first-page":"6808061","article-title":"KIR\/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico","volume":"2019","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-017-0630-3","article-title":"Innate Immunity in Systemic Sclerosis","volume":"19","author":"Dowson","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cei.13452","article-title":"Innate immunity in systemic sclerosis","volume":"201","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/kjm2.12505","article-title":"Pathophysiology of systemic sclerosis (scleroderma)","volume":"38","author":"Rosendahl","year":"2022","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"582401","DOI":"10.3389\/fimmu.2020.582401","article-title":"Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis","volume":"11","author":"Vlachogiannis","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fimmu.2013.00266","article-title":"The role of type 1 interferon in systemic sclerosis","volume":"4","author":"Wu","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ramaswamy, M., Tummala, R., Streicher, K., Nogueira da Costa, A., and Brohawn, P.Z. (2021). The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011286"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/BOR.0000000000000653","article-title":"Interferon-signature in idiopathic inflammatory myopathies","volume":"31","author":"Gallay","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1169057","DOI":"10.3389\/fimmu.2023.1169057","article-title":"Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/mr\/roac140","article-title":"Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven disease","volume":"33","author":"Tanaka","year":"2023","journal-title":"Mod. Rheumatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12016-020-08798-2","article-title":"Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases","volume":"59","author":"Jiang","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e002687","DOI":"10.1136\/rmdopen-2022-002687","article-title":"Interferon signature in systemic autoimmune diseases: What does it mean?","volume":"8","author":"Nocturne","year":"2022","journal-title":"RMD Open"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Negishi, H., Taniguchi, T., and Yanai, H. (2018). The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family. Cold Spring Harb. Perspect. Biol., 10.","DOI":"10.1101\/cshperspect.a028423"},{"key":"ref_57","first-page":"4531","article-title":"Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system","volume":"13","author":"Tanaka","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbagrm.2008.08.003","article-title":"Interferon-sensitive response element (ISRE) is mainly responsible for IFN-\u03b1-induced upregulation of programmed death-1 (PD-1) in macrophages","volume":"1779","author":"Cho","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Gene Regul. Mech."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-3-030-92616-8_10","article-title":"The Immunogenetics of Systemic Sclerosis","volume":"1367","author":"Rajabi","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00296-017-3722-5","article-title":"The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms","volume":"37","author":"Zhao","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10067-019-04922-6","article-title":"Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease","volume":"39","author":"Stock","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/s41598-020-58741-w","article-title":"A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn\u2019s disease","volume":"10","author":"Ochoa","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.39730","article-title":"Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies","volume":"68","author":"Assassi","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Gorlova, O., Martin, J.E., Rueda, B., Koeleman, B.P., Ying, J., Teruel, M., Diaz-Gallo, L.M., Broen, J.C., Vonk, M.C., and Simeon, C.P. (2011). Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet., 7.","DOI":"10.1371\/annotation\/7a52649c-0942-4bd8-a5d3-3cdacca03cd8"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/art.37777","article-title":"PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population","volume":"65","author":"Terao","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jid.2021.02.015","article-title":"Downregulated IRF8 in Monocytes and Macrophages of Patients with Systemic Sclerosis May Aggravate the Fibrotic Phenotype","volume":"141","author":"Ototake","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kotyla, P.J. (2018). Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?. BioMed Res. Int., 2018.","DOI":"10.1155\/2018\/7492904"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gumkowska-Sroka, O., Kotyla, K., Mojs, E., Palka, K., and Kotyla, P. (2023). Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis. Pharmaceuticals, 16.","DOI":"10.20944\/preprints202306.0143.v1"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Kotyla, P., Gumkowska-Sroka, O., Wnuk, B., and Kotyla, K. (2022). Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus. Pharmaceuticals, 15.","DOI":"10.3390\/ph15080936"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2217\/fvl-2018-0033","article-title":"STAT3 roles in viral infection: Antiviral or proviral?","volume":"13","author":"Chang","year":"2018","journal-title":"Future Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddp119","article-title":"The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype","volume":"18","author":"Rueda","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_73","first-page":"20","article-title":"The influence of STAT4 rs7574865 (G\/T) polymorphism on the risk of clinical and immunological phenotypes of systemic sclerosis in a Russian patient population: Results of a pilot study","volume":"89","author":"Krylov","year":"2017","journal-title":"Ter. Arkhiv"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","article-title":"STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis","volume":"60","author":"Guedj","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/ard.2009.111310","article-title":"Association of STAT4 polymorphism with systemic sclerosis in a Japanese population","volume":"68","author":"Tsuchiya","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/art.24958","article-title":"Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: Evidence of possible gene-gene interaction and alterations in Th1\/Th2 cytokines","volume":"60","author":"Gourh","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/2397198319865367","article-title":"The JAK\/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib","volume":"5","author":"Wang","year":"2019","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41467-017-01236-6","article-title":"Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/annrheumdis-2015-208154","article-title":"Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway","volume":"75","author":"Guerra","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cei.13426","article-title":"Toll-like receptors in mediating pathogenesis in systemic sclerosis","volume":"201","author":"Frasca","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.33325","article-title":"A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators","volume":"64","author":"Broen","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Lawrence, T. (2009). The nuclear factor NF-\u03baB pathway in inflammation. Cold Spring Harb. Perspect. Biol., 1.","DOI":"10.1101\/cshperspect.a001651"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.12458","article-title":"Mechanism of NLRP3 inflammasome activation","volume":"1319","author":"Sutterwala","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_85","first-page":"306","article-title":"Transcriptional activity of nuclear factor \u03baB family genes in patients with systemic sclerosis","volume":"47","author":"Gola","year":"2017","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1038\/s41467-019-12760-y","article-title":"GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways","volume":"10","author":"Kerick","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/rheumatology\/key281","article-title":"Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study","volume":"58","author":"Yilmaz","year":"2019","journal-title":"Rheumatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"640083","DOI":"10.3389\/fimmu.2021.640083","article-title":"Association of GTF2I, NFKB1, and TYK2 Regional Polymorphisms with Systemic Sclerosis in a Chinese Han Population","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/ard.2009.127928","article-title":"Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population","volume":"69","author":"Dieude","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.39476","article-title":"Identification of an association of TNFAIP3 polymorphisms with matrix metalloproteinase expression in fibroblasts in an integrative study of systemic sclerosis\u2013associated genetic and environmental factors","volume":"68","author":"Wei","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13075-016-1118-7","article-title":"A20 suppresses canonical Smad-dependent fibroblast activation: Novel function for an endogenous inflammatory modulator","volume":"18","author":"Bhattacharyya","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3491269","DOI":"10.1155\/2018\/3491269","article-title":"TNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling","volume":"2018","author":"Shamilov","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Allanore, Y., Saad, M., Dieud\u00e9, P., Avouac, J., Distler, J.H., Amouyel, P., Matucci-Cerinic, M., Riemekasten, G., Airo, P., and Melchers, I. (2011). Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet., 7.","DOI":"10.1371\/journal.pgen.1002091"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"108024","DOI":"10.1016\/j.pharmthera.2021.108024","article-title":"Macrophage migration inhibitory factor (MIF): A multifaceted cytokine regulated by genetic and physiological strategies","volume":"233","author":"Sumaiya","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/ard.62.5.460","article-title":"Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis","volume":"62","author":"Selvi","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e1042","DOI":"10.1002\/cti2.1042","article-title":"Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis","volume":"7","author":"Vincent","year":"2018","journal-title":"Clin. Transl. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/art.22179","article-title":"Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma","volume":"54","author":"Wu","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3899\/jrheum.161369","article-title":"An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis","volume":"44","author":"Carmona","year":"2017","journal-title":"J. Rheumatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/rheumatology\/ker259","article-title":"Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population","volume":"50","author":"Simeon","year":"2011","journal-title":"Rheumatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: Current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"102461","DOI":"10.1016\/j.autrev.2020.102461","article-title":"IRAK family in inflammatory autoimmune diseases","volume":"19","author":"Su","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2009.03.005","article-title":"Female predominance and X chromosome defects in autoimmune diseases","volume":"33","author":"Invernizzi","year":"2009","journal-title":"J. Autoimmun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1002\/art.30640","article-title":"Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: Association with the functional IRAK1 196Phe\/532Ser haplotype","volume":"63","author":"Bouaziz","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jaci.2009.09.017","article-title":"Adaptive immunity","volume":"125","author":"Bonilla","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Koretzky","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e13170","DOI":"10.1111\/sji.13170","article-title":"Advances in CD247","volume":"96","author":"Dexiu","year":"2022","journal-title":"Scand. J. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/gene.2014.73","article-title":"Genetic association of CD247 (CD3\u03b6) with SLE in a large-scale multiethnic study","volume":"16","author":"Martins","year":"2015","journal-title":"Genes Immun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/rheumatology\/ket119","article-title":"CD247 variants and single-nucleotide polymorphisms observed in systemic lupus erythematosus patients","volume":"52","author":"Takeuchi","year":"2013","journal-title":"Rheumatology"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Teruel, M., McKinney, C., Balsa, A., Pascual-Salcedo, D., Rodriguez-Rodriguez, L., Ortiz, A.M., G\u00f3mez-Vaquero, C., Gonz\u00e1lez-Gay, M.A., Smith, M., and Witte, T. (2013). Association of CD247 polymorphisms with rheumatoid arthritis: A replication study and a meta-analysis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068295"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"100613","DOI":"10.1016\/j.mgene.2019.100613","article-title":"Association between CD247 gene rs2056626 polymorphism and the risk of systemic sclerosis: Evidence from a systematic review and Bayesian hierarchical meta-analysis","volume":"22","author":"Vanaki","year":"2019","journal-title":"Meta Gene"},{"key":"ref_112","first-page":"471","article-title":"Association Study of CD226 and CD247 Genes Single Nucleotide Polymorphisms in Iranian Patients with Systemic Sclerosis","volume":"16","author":"Abbasi","year":"2017","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1874312901408010043","article-title":"Lack of Association of the CD247 SNP rs2056626 with Systemic Sclerosis in Han Chinese","volume":"8","author":"Wang","year":"2014","journal-title":"Open Rheumatol. J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1136\/ard.2010.147009","article-title":"Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor","volume":"70","author":"Boileau","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.42396","article-title":"Identification of Mechanisms by Which Genetic Susceptibility Loci Influence Systemic Sclerosis Risk Using Functional Genomics in Primary T Cells and Monocytes","volume":"75","author":"Shi","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/187152809787582507","article-title":"The IL-12 Family of Cytokines in Infection, Inflammation and Autoimmune Disorders","volume":"8","author":"Gee","year":"2009","journal-title":"Inflamm. Allergy\u2014Drug Targets (Discontin.)"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"ref_118","first-page":"2838","article-title":"Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis","volume":"27","author":"Sato","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_119","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: Association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J. Rheumatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","article-title":"Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis","volume":"94","author":"Mayes","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1002\/art.38870","article-title":"Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus","volume":"66","author":"Guerra","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13073-020-00779-6","article-title":"Epigenomics and Transcriptomics of Systemic Sclerosis CD4+ T cells reveal Long Range Dysregulation of Key Inflammatory Pathways mediated by disease-associated Susceptibility Loci","volume":"12","author":"Li","year":"2020","journal-title":"Genome Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/hmg\/dds099","article-title":"A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations","volume":"21","author":"Martin","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar2414","article-title":"T-cell co-stimulatory pathways in autoimmunity","volume":"10","author":"Goronzy","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-065X.2009.00766.x","article-title":"The significance of OX40 and OX40L to T-cell biology and immune disease","volume":"229","author":"Croft","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2010.141838","article-title":"A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort","volume":"70","author":"Broen","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.2009.116434","article-title":"Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis","volume":"69","author":"Gourh","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.111270","article-title":"Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis","volume":"39","author":"Coustet","year":"2012","journal-title":"J. Rheumatol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Kosa\u0142ka-W\u0119giel, J., Licho\u0142ai, S., Dziedzina, S., Milewski, M., Kuszmiersz, P., Rams, A., G\u0105sior, J., Matyja-Bednarczyk, A., Kwiatkowska, H., and Korkosz, M. (2022). Genetic Association between TNFA Polymorphisms (rs1799964 and rs361525) and Susceptibility to Cancer in Systemic Sclerosis. Life, 12.","DOI":"10.3390\/life12050698"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"721608","DOI":"10.1155\/2011\/721608","article-title":"The many faces of interleukin-6: The role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis","volume":"2011","author":"Barnes","year":"2011","journal-title":"Int. J. Rheumatol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.5301\/jsrd.5000258","article-title":"Contribution of Interleukin-6 to the Pathogenesis of Systemic Sclerosis","volume":"2","author":"Kawaguchi","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2010.133587","article-title":"Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: A novel target for systemic sclerosis?","volume":"70","author":"Barnes","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2018.08.003","article-title":"Targeting TLRs and the inflammasome in systemic sclerosis","volume":"192","author":"Henderson","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"R1113","DOI":"10.1186\/ar1790","article-title":"Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis","volume":"7","author":"Rajkumar","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin. Investig."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.24730","article-title":"Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument","volume":"61","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_137","first-page":"522","article-title":"The IL-6 promoter polymorphism is associated with severity and disability in systemic sclerosis","volume":"65","author":"Mihai","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/art.23836","article-title":"Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients","volume":"59","author":"Beretta","year":"2008","journal-title":"Arthritis Rheum."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/5\/586\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:39:48Z","timestamp":1760107188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/5\/586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,5]]},"references-count":138,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["genes15050586"],"URL":"https:\/\/doi.org\/10.3390\/genes15050586","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,5]]}}}